From Drew Altman June 21, 2024 Page From Drew Altman Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the…
Hagere Yilma May 30, 2023 Person Hagere Yilma is the senior manager of the Health Misinformation and Trust Initiative at KFF. In this role, Yilma is developing a new program aimed at combatting health misinformation and fostering trust in news and media. Previously, Yilma collaborated with global organizations, including the World Health Organization and the World…
How Much and Why ACA Marketplace Premiums Are Going Up in 2025 August 5, 2024 Issue Brief This analysis of insurers’ preliminary rate filings shows that ACA Marketplace insurers are requesting a median premium increase of 7% for 2025, similar to the 6% premium increase filed for 2024. Insurers cite growing health care prices – particularly for hospital care – as a key driver of premium growth in 2025.
What are the Recent Trends in Employer-Based Health Coverage? December 22, 2023 Issue Brief This chart collection presents analysis of data from recent Annual Economic and Social Supplements (ASEC) of the Current Population Survey (CPS) to examine who among non-elderly people has employer-sponsored insurance and which workers are offered and eligible for coverage at their current jobs.
How Many People with Employer-Sponsored Insurance Use the Drugs Slated for Medicare Price Negotiations August 14, 2024 Issue Brief Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations, according to a new analysis. The most used drug for people with employer-sponsored health insurance was Jardiance, a drug used to treat diabetes and…
Insurer Strategies to Control Costs Associated with Weight Loss Drugs June 12, 2024 Issue Brief Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a an analysis of 2024 federal plan data. Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace prescription drug plans, compared to 82% of Marketplace prescription…
What are the Trends in Health Utilization and Spending in Early 2024? August 20, 2024 Issue Brief Recent trends in healthcare utilization and spending suggest that most spending on health services exceeds pre-pandemic levels and health costs are growing at a faster rate than in recent years. However, utilization of care has been uneven by setting and market. For example, some measures of hospital utilization remain lower…
Compare the Candidates on Health Care Policy August 5, 2024 Page The side-by-side comparison tool provides a quick overview of former President Trump’s and Vice President Harris’ records, positions, public statements, and proposed policies on a range of key health care topics.
What the FTC’s New Protections From Non-Compete Agreements Mean in a Mostly Non-Profit Hospital Industry July 24, 2024 Blog This analysis uses 2022 data from the American Hospital Association (AHA) Annual Survey Database to present the number and share of hospital workers by occupation who may not be covered by the federal protections against non-compete agreements because they work for a non-profit hospital.